Leukaemia drug ‘improves immune response against other cancers’

12 June 2014

Experimental medicines, currently being tested for the treatment of leukaemia, could also boost the body’s immune response against other types of cancer, suggests new research from University College London (UCL).

The drugs target a protein - p110δ - which is produced in vast quantities in white blood cells called leukocytes.

Leukaemia arises when these cells become cancerous, at which point p110δ becomes a target for treatments.

Recent clinical trials testing the effectiveness of these drugs have shown encouraging results and the latest research reveals they boost the body’s immune response against several tumour types.

The team behind the new study demonstrated that p110δ inhibitors worked by disarming a family of immune cells and releasing another type that is able to target, as well as kill, tumour cells.

According to the researchers, these findings suggest the inhibitors could harness the power of the body’s own immune system when combined with other treatments.

Professor Nic Jones, chief scientist for Cancer Research UK, which part-funded the research, said: “This new finding, although only at an early stage, offers the potential to develop more treatments that can do this in many more cancers, including ones that have real need for more effective treatments such as pancreatic cancer.

“If the findings hold true in cancer patients this could make a big difference to many of them.”

Posted by Jeanette Royston


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)